Who owns the TOLERO PHARMACEUTICALS trademark?

The TOLERO PHARMACEUTICALS trademark is owned by Sumitomo Dainippon Pharma Co., Ltd..

What is the serial number for TOLERO PHARMACEUTICALS?

The USPTO serial number for TOLERO PHARMACEUTICALS is 79212382.

What is the registration number for TOLERO PHARMACEUTICALS?

TOLERO PHARMACEUTICALS is registered under USPTO registration number 5505386.

TOL

USPTO Trademark Record

ABANDONED

TOLERO PHARMACEUTICALS

Q: What class is the TOLERO PHARMACEUTICALS trademark registered in?

The TOLERO PHARMACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

SN 79212382·Reg 5505386·Filed Mar 22, 2017

Owner Sumitomo Dainippon Pharma Co., Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

TOLERO PHARMACEUTICALS (Serial No. 79212382), Registration No. 5505386, is a abandoned US trademark filed on Mar 22, 2017 by Sumitomo Dainippon Pharma Co., Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

Mark Intelligence

TOLERO PHARMACEUTICALS (Reg. #5505386) is an abandoned US trademark that was filed in 2017 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Mar 22, 2017

SERIAL

79212382

REG#

5505386

REGISTERED

Jul 03, 2018

Owner

Applicant

Sumitomo Dainippon Pharma Co., Ltd.

Entity

Corporation

Address

6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-0045

Country

Attorney

NameHoward N. Aronson

Law firm

Howard N. Aronson Lackenbach Siegel LLP

Docket

20578

Address

1 Chase Rd., Lackenbach Siegel Bldg., Scarsdale, NY 10583-4156, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 22, 2017

Serial Number79212382

Registration No.5505386

Registration DateJul 03, 2018

Status DateJan 17, 2025

Published for OppositionApr 17, 2018

Mark TypeStandard characters

Attorney Docket20578

Status DescriptionDead and cancelled, Section 71

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

40 events

TOTAL INVALIDATION PROCESSED BY THE IB

Mar 19, 2026

TOTAL INVALIDATION PROCESSED BY THE IB

INVALIDATION PROCESSED

Feb 28, 2026

INVALIDATION PROCESSED

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Feb 28, 2026

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Sep 17, 2025

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

CANCELLED SECTION 71

Jan 17, 2025

CANCELLED SECTION 71

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jul 03, 2023

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Oct 26, 2018

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Oct 04, 2018

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Oct 04, 2018

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 03, 2018

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jul 03, 2018

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Apr 17, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 17, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Apr 13, 2018

NOTIFICATION PROCESSED BY IB

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Mar 28, 2018

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 28, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 28, 2018

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 15, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 14, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 13, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 13, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Dec 22, 2017

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 22, 2017

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 22, 2017

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 19, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 19, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Dec 15, 2017

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 07, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 08, 2017

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 08, 2017

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

REFUSAL PROCESSED BY IB

Aug 12, 2017

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jul 27, 2017

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 27, 2017

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

APPLICATION FILING RECEIPT MAILED

Jul 25, 2017

APPLICATION FILING RECEIPT MAILED

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 21, 2017

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jul 20, 2017

NON-FINAL ACTION WRITTEN

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 19, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Jul 19, 2017

ASSIGNED TO EXAMINER

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Jul 14, 2017

LIMITATION FROM ORIGINAL APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jul 13, 2017

SN ASSIGNED FOR SECT 66A APPL FROM IB

TOLERO PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Sumitomo Dainippon Pharma Co., Ltd.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Howard N. Aronson

Resources

Company